Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor

Authors

David C Dale, University of Washington
Audrey Anna Bolyard, University of Washington
James A Shannon, University of Washington
James A Connelly, Vanderbilt University
Daniel C Link, Washington University School of Medicine in St. Louis
Mary Ann Bonilla, St. Joseph's Children's Hospital
Peter E Newburger, University of Massachusetts

Journal

Blood Advances

Publication Date

7-12-2022

Volume

6

Issue

13

First Page

3861

Last Page

3869

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2021005684

Rights and Permissions

Dale DC, Bolyard AA, Shannon JA, Connelly JA, Link DC, Bonilla MA, Newburger PE. Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor. Blood Adv. 2022 Jul 12;6(13):3861-3869. doi: 10.1182/bloodadvances.2021005684 © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Dale, David C; Bolyard, Audrey Anna; Shannon, James A; Connelly, James A; Link, Daniel C; Bonilla, Mary Ann; and Newburger, Peter E, "Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor." Blood Advances. 6, 13. 3861 - 3869. (2022).
https://digitalcommons.wustl.edu/oa_4/326